Abstract
Naphtho[2,3-f]indole-5,10-dione aminoalkyl derivatives in cytotoxic concentrations inhibit topoisomerase I, which is an important factor of antitumor activity of compounds of this chemical class. The degree of topoisomerase I inhibition with naphtho[2,3-f]indole-5,10-dione derivatives depends on the structure and position of active (aminoalkyl) groups. The mechanism of topoisomerase I inhibition with aminoalkylnaphtho[2,3-f]indole-5,10-diones differs from specific blocking of the catalytic activity of the enzyme and depends on interactions of these compounds with DNA.
References
A. A. Adjei, M. Charron, and E. K. Rowinsky, Clin. Cancer Res., 4, No. 3, 683–691 (1998).
W. A. Denny, Expert Opin. Emerg. Drugs, 9, No. 1, 105–133 (2004).
M. Facompre, C. Carrasco, P. Colson, et al., Mol. Pharmacol., 62, No. 5, 1215–1227 (2002).
P. D. Foglesong, C. Reckord, and S. Swink, Cancer Chemother. Pharmacol., 30, No. 2, 123–125 (1992).
L. F. Liu, Annu. Rev. Biochem., No. 58, 351–375 (1989).
A. E. Shchekotikhin, L. G. Dezhenkova, O. Y. Susova, et al., Bioorg. Med. Chem., 15, No. 7, 2651–2659 (2007).
A. E. Shchekotikhin, V. A. Glazunova, Y. N. Luzikov, et al., Ibid., 14, No. 15, 5241–5251 (2006).
A. E. Shchekotikhin, A. A. Shtil, Y. N. Luzikov, et al., Ibid., 13, No. 6, 2285–2291 (2005).
L. Shen, Methods in Molecular Biology: DNA Topoisomerase Protocols, Part II: Enzymology and Drugs, Totova (2001), Vol. 95, P. 149.
Author information
Authors and Affiliations
Corresponding author
Additional information
__________
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 145, No. 3, pp. 304–308, March, 2008
Rights and permissions
About this article
Cite this article
Dezhenkova, L.G., Susova, O.Y., Shchekotikhin, A.E. et al. Naphtho[2,3-f]indole-5,10-dione aminoalkyl derivatives: A new class of topoisomerase I inhibitors. Bull Exp Biol Med 145, 334–337 (2008). https://doi.org/10.1007/s10517-008-0084-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-008-0084-8